Trial drug can significantly block early stages of COVID-19 in engineered human tissues An international team has found a trial drug that effectively blocks the cellular door SARS-CoV-2 uses to infect its hosts. Source: Trial drug can significantly block early stages of COVID-19 in engineered human tissues — ScienceDaily Share this:TwitterFacebookLike this:Like Loading... Related
An international team has found a trial drug that effectively blocks the cellular door SARS-CoV-2 uses to infect its hosts.An international team has found a trial drug that effectively blocks the cellular door SARS-CoV-2 uses to infect its hosts.
Darwiniana 